Method for treatment of lupus nephritis

Details Method for treatment of lupus nephritis Method for treatment of lupus nephritis

A - Human Necessities

61

K

A61K 31/7016 (2006.01) A61K 31/09 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2193553

It has been found that by administering secoisolariciresinol [2,3-bis(3-methyl-4-hydroxybenzyl)butane- 1,4-diol] from flaxseed in substantially pure form to a human or non-human animal, lupus nephritis can be controlled. The secoisolariciresinol (Seco) may be used per se or in the form of secoisolariciresinol diglucoside (SDG). Both compounds may be extracted from flaxseed and the SDG converts to Seco in the gut of a human or animal.

Affiliated with

Also associated with

Rating

Method for treatment of lupus nephritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment of lupus nephritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of lupus nephritis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1564619